Insider · CIK 0001839260
Vivek Garipalli
Files at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). First filing Aug 8, 2025, latest Aug 8, 2025.
In brief
Vivek Garipalli files SEC Form 4 as director and 10% owner at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). Since Aug 8, 2025, Vivek Garipalli has reported 1 open-market buy worth $999k and 0 open-market sells worth $0, the latest filed on Aug 8, 2025.
A track record needs three past buys with six months of prices behind them; Vivek Garipalli has 0, so none is measured yet.
The newest scored trade: bought $999k of CLOV on Aug 7, 2025, filed Aug 8, 2025, scored 72 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLOV: CLOVER HEALTH INVESTMENTS, CORP. /DE
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 72Notable | CLOVER HEALTH INVESTMENTS, CORP. /DE | $999k 446,980 shares | +32% | 0% from low-54% from high |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class A Common Stock | +1,655,949 | $0.00 | $0 | 3,512,196 | Jan 9, 2026 |
| Jan 7, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | FTax withholding Class A Common Stock | -1,655,949 | $2.59 | $4.3M | 1,856,247 | Jan 9, 2026 |
| Jan 7, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Restricted Stock Unitderivative | -3,342,699 | - | - | 0 | Jan 9, 2026 |
| Jan 7, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class B Common Stockderivative | +3,342,699 | - | - | 10,247,042 | Jan 9, 2026 |
| Jan 7, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class B Common Stockderivative | -1,655,949 | - | - | 8,591,093 | Jan 9, 2026 |
| Aug 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | POpen-market purchase Class A Common Stock | +415,000 | $2.24 | $930k | 1,824,267 | Aug 8, 2025 |
| Aug 8, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | POpen-market purchase Class A Common Stock | +31,980 | $2.17 | $69k | 1,856,247 | Aug 8, 2025 |
| Jan 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class A Common Stock | +1,670,965 | $0.00 | $0 | 3,080,232 | Jan 10, 2025 |
| Jan 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | FTax withholding Class A Common Stock | -1,670,965 | $3.60 | $6.0M | 1,409,267 | Jan 10, 2025 |
| Jan 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Restricted Stock Unitderivative | -3,342,698 | - | - | 3,342,699 | Jan 10, 2025 |
| Jan 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class B Common Stockderivative | +3,342,698 | - | - | 8,575,308 | Jan 10, 2025 |
| Jan 7, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class B Common Stockderivative | -1,670,965 | - | - | 6,904,343 | Jan 10, 2025 |
| Jan 7, 2024 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class A Common Stock | +1,561,065 | - | - | 1,561,065 | Jan 9, 2024 |
| Jan 7, 2024 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | FTax withholding Class A Common Stock | -1,561,065 | $0.95 | $1.5M | 0 | Jan 9, 2024 |
| Jan 7, 2024 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Restricted Stock Unitderivative | -3,342,698 | - | - | 6,685,397 | Jan 9, 2024 |
| Jan 7, 2024 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class B Common Stockderivative | +3,342,698 | - | - | 6,793,675 | Jan 9, 2024 |
| Jan 7, 2024 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | MOption exercise Class B Common Stockderivative | -1,561,065 | - | - | 5,232,610 | Jan 9, 2024 |
Questions about Vivek Garipalli
Answered from the filings on this page, as of the latest one.
Is Vivek Garipalli buying or selling?
Not in the last 12 months. Vivek Garipalli's latest open-market trade on SEC Form 4 was bought $999k of CLOV on Aug 7, 2025.
How did Vivek Garipalli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vivek Garipalli has 0.
Where does Vivek Garipalli file Form 4?
Vivek Garipalli has filed Form 4 at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.